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Abstract: 
While the traditional model of genetic evaluation for breast cancer risk recommended face-to-
face disclosure of genetic testing results, BRCA1/2 testing results are increasingly provided by 
telephone. The few existing studies on telephone genetic counseling provide conflicting results 
about its desirability and efficacy. The current study aimed to (1) Estimate the prevalence among 
genetic counselors of providing BRCA1/2 genetic test results by phone (2) Assess patient 
satisfaction with results delivered by telephone versus in-person. A survey was sent to members 
of the Familial Cancer Risk Counseling Special Interest Group via the NSGC listserve and was 
completed by 107 individuals. Additionally, 137 patients who had received BRCA genetic 
testing results either by phone or in-person at UNC Chapel Hill Cancer Genetics Clinic were 
surveyed regarding satisfaction with the mode of their BRCA1/2 results delivery. The genetic 
counseling survey revealed that the majority of responding counselors (92.5%) had delivered 
BRCA1/2 genetic test results by telephone. Patients having received results either in person or by 
phone reported no difference in satisfaction. Most patients chose to receive results by phone and 
those given a choice of delivery mode reported significantly higher satisfaction than those who 
did not have a choice. Those who waited less time to receive results once they knew they were 
ready also reported higher satisfaction. This study found supportive results for the routine 
provision of BRCA1/2 genetic test results by telephone. Results suggest that test results should 
be delivered as swiftly as possible once available and that offering patients a choice of how to 
receive results is desirable. These are especially important issues as genetic testing becomes 
more commonplace in medicine. 
 ethics | genetics | genetic counseling | clinical psychology | breast cancer | breast Keywords:
cancer risk | telephone genetic counseling 
Article: 
Introduction 
 
According to the American Cancer Society, breast cancer is the most frequently diagnosed 
cancer in women and the second leading cause of cancer deaths in women after lung cancer 
(American Cancer Society 2008). Approximately 180,000 new cases of breast cancer are 
diagnosed each year, with over 40,000 deaths from this disease (National Cancer Institute 2008). 
Mutations in the BRCA1 and BRCA2 genes result in a substantially increased risk for 
developing breast and ovarian cancer. The normal gene products act as tumor suppressors and 
confer risk through mutation of the wild type allele and subsequent loss of function of tumor 
suppressor activity (Petrucelli et al. 2005). Estimates for the penetrance of mutations in BRCA1 
and BRCA2 have varied, but appear to confer a lifetime risk for women of up to 87% for 
developing breast cancer and up to 68% for the development of ovarian cancer (National Cancer 
Institute 2008). The prevalence of BRCA1/2 mutations in the general U.S. population is 1–2 per 
1,000, and genetic testing for these mutations has been available to the general public since 1996 
(Petrucelli et al. 2005). 
 
Regarding BRCA1/2 mutation testing, the current guidelines recommend testing be performed 
after provision of pre-test education by a trained genetics professional and formal client consent. 
The process of informed decision-making may or may not be completed in a single visit and final 
testing results should be provided in person by the same genetics professional who performed the 
pre-test counseling (American College of Medical Genetics Foundation 1999). Due to the nature 
of results disclosure and the fact that post-test counseling is a multi-step process, the NSGC 
recommends that this process optimally be done face-to-face. Elements included in this session 
are not only results disclosure, but discussion of impact of test results, medical management 
decisions, informing other relatives, encouragement of future contact with the clinic, and 
provision of additional resources and support services, all of which may be difficult to 
adequately address over the telephone or in a letter (Trepanier et al. 2004). Billing and legal 
issues may also pose barriers for genetic counseling by telephone (Ormond et al. 2000). For 
these reasons, current guidelines suggest telephone counseling for test result disclosure only in 
special circumstances, such as for clients who do not live locally or who are terminally ill. 
Consequently, most cancer programs in the past have required at least two clinic visits, a pretest 
visit and results disclosure visit, with some programs requiring additional visits (Schneider 
2002). 
The recommendations of The American College of Medical Genetics (1999) and NSGC have 
been influenced greatly by the protocol established for pre-symptomatic Huntington Disease 
(HD) testing (Baker et al. 1998; International Huntington Association and World Federation of 
Neurology Research Group on Huntington’s Chorea 1994) which recommends three in-person 
visits with a genetics professional as well as psychological and neurological evaluations. 
Advocates for modeling familial breast cancer genetic testing protocols on the HD model have 
noted that genetic testing for both conditions is predictive in nature. However, crucial differences 
between the two diseases include the fact that preventive measures are available in the realm of 
breast cancer risk and that the population prevalence of mutations in BRCA1/2 far exceed that of 
mutations in the HD gene. Given the increasing frequency of BRCA1/2 genetic testing in routine 
clinical care, its established role as an important aspect of oncologic care for many women and 
little (if any) evidence of harm resulting from such testing, it is reasonable to re-examine the 
need for in-person results disclosure. 
Ideally, telephone counseling can provide a clinical service that is efficacious, convenient, cost-
effective, accessible and educational, while at the same time maximizing the efficiency of clinics 
so that they can serve a maximal number of patients. The service is becoming increasingly more 
prevalent for prenatal teratogen counseling and is a standard method for delivering prenatal 
genetic test results (Ormond et al. 2000). Genetic counselors surveyed in a previous study 
(Young 1993) indicated that the majority utilized the telephone to discuss and deliver 
information to patients, including delivery of normal test results, and were motivated to do so 
primarily by the patient’s convenience. However, the majority of counselors in this study also 
reported never delivering inconclusive or abnormal test results over the telephone. Consequently, 
there is interest in determining the feasibility of providing high-quality counseling in the context 
of BRCA1/2 testing results by telephone. 
A number of studies have investigated various facets of telephone delivery of breast cancer risk 
information and BRCA1/2 genetic testing results. These studies have previously shown that both 
in-person and telephone counseling and results delivery have been generally well-received 
(Helmes et al. 2006; Klemp et al. 2005). One observed difference, however, was that patients 
who received breast cancer risk counseling by telephone found it more difficult to talk about 
their concerns with one woman reporting that her telephone counseling session was “easier to 
become distracted than face-to-face”. Another difference found was that more women who 
received telephone counseling would rather have received in-person counseling (Helmes et al. 
2006). In regard to results delivery, no difference in satisfaction has been shown between those 
who receive BRCA1/2 genetic testing results over the phone versus those who receive results in 
person (Chen et al. 2002; Jenkins et al. 2007). When given a choice as to how to receive results, 
most individuals choose to receive their BRCA1/2 genetic testing results by telephone (Klemp et 
al. 2005). No previous studies have reported the prevalence of telephone usage to provide cancer 
genetic test results, nor the specific circumstances under which these test results are being 
provided by telephone. Thus, there is need for current and further investigation of telephone 
BRCA counseling and results delivery. 
As discussed by Peshkin et al. (2008), genetic counseling and testing services are increasing, 
particularly as additional genes are characterized and additional genetic tests become clinically 
available. Exploring alternative methods to traditional face-to face genetic counseling is 
imperative to devise service delivery mechanisms which meet this increase in demand. One of 
these methods, utilizing the telephone for counseling and/or delivery of results, has been and is 
currently utilized, but there exists a lack of data about its use and effectiveness from patient and 
provider perspectives. In this study we investigated the prevalence of provision of BRCA1/2 
results by telephone among genetic counselors in the U.S as well as patient satisfaction with the 
mode of results delivery at our institution. The results have broad implications for medical 
management as the impact of genetics continues to expand in medicine. 
Methods 
 
This study consisted of two parts, Current Genetic Counseling Practices and Patient Satisfaction. 
The study was conducted under the approval of the University of North Carolina Chapel Hill 
IRB and the University of North Carolina Greensboro IRB. 
Part I: Current Genetic Counseling Practices 
 
The first part of the study assessed the prevalence and circumstances accompanying delivery of 
BRCA1/2 genetic test results by telephone in current cancer genetic counseling practices 
throughout the US. Members of the National Society of Genetic Counselors (NSGC) Familial 
Cancer Risk Counseling Special Interest Group (SIG) (n = 476) were sent an invitation through 
their listserv to an electronic survey adapted to Survey Monkey. This group was selected to 
survey because it represents a large accessible population of practicing cancer genetic 
counselors. 
The survey (see Appendix A) was developed by the researchers as an original measure and 
piloted to several practicing genetic counselors. The measure included questions to ascertain how 
many counselors currently deliver BRCA1/2 genetic test results by telephone, what percentage 
of their patient population is receiving results in this manner, and the clinical and social 
circumstances of the patients for whom results are provided by telephone. A list of circumstances 
under which a counselor may or may not deliver BRCA1/2 genetic test results over the phone 
was provided for negative and positive results. The counselor was then asked to answer whether 
they usually, sometimes, rarely, or never provide results over the telephone for each 
circumstance (Table 1). 
Table 1 
Reported Frequency of BRCA1/2 Test Results Delivery According to Type of Result and Circumstance 
  
POSITIVE % Respondents (N) NEGATIVE % Respondents (N) 
Usually Sometimes Rarely Never 
Total 
N Usually Sometimes Rarely Never 
Total 
N 
When patients are unable to 
return to clinic for results due 
to illness or travel issues 
27.5% 13.2% 20.9% 38.5% 
(91) 
34.8% 27.2% 26.1% 12.0% 
(92) (25) (12) (19) (35) (32) (25) (24) (11) 
When patients refuse to return 
to clinic for results 
16.7% 5.6% 14.4% 63.3% 
(90) 
20.9% 11.0% 18.7% 49.5% 
(91) (15) (5) (13) (57) (19) (10) (17) (45) 
When patients choose to have 
their results delivered by 
telephone 
26.9% 7.5% 15.1% 50.5% 
(93) 
29.0% 14.0% 17.2% 39.8% 
(93) (25) (7) (14) (47) (27) (13) (16) (37) 
When results are for the first 
person being tested in a 
family 
20.2% 10.6% 19.1% 50.0% 
(94) 
26.9% 11.8% 18.3% 43.0% 
(93) (19) (10) (18) (47) (25) (11) (17) (40) 
When results are for someone 
21.3% 10.6% 19.1% 48.9% (94) 25.8% 20.4% 21.5% 32.3% (93) 
  
POSITIVE % Respondents (N) NEGATIVE % Respondents (N) 
Usually Sometimes Rarely Never 
Total 
N Usually Sometimes Rarely Never 
Total 
N 
tested from a family with a 
known familial mutation (20) (10) (18) (46) (24) (19) (20) (30) 
When I am confident that the 
patient comprehended the 
information discussed during 
pre-test counseling 
24.5% 7.4% 20.2% 47.9% 
(93) 
30.4% 13.0% 25.0% 31.5% 
(92) (23) (7) (19) (45) (28) (12) (23) (29) 
When, in my clinical 
judgment, I believe that my 
patient is not at risk for an 
intense emotional response to 
the result 
24.5% 8.5% 14.9% 52.1% 
(94) 
29.7% 14.3% 22.0% 34.1% 
(91) (23) (8) (14) (49) (27) (13) (20) (31) 
When I feel confident that I 
will have an opportunity to 
follow up with the patient 
face to face 
27.2% 12.0% 19.6% 41.3% 
(92) 
29.0% 18.3% 26.9% 25.8% 
(93) (25) (11) (18) (38) (27) (17) (25) (24) 
Genetic counselors who responded that they do not deliver any BRCA1/2 test results to patients 
were excluded from the study. One hundred seven qualifying individuals responded to the 
invitation by completing the survey yielding an estimated response rate of 22.5%. The survey 
was anonymous and submission of the survey was electronic. 
The survey was available for 4 weeks, and an electronic reminder letter was issued to the NSGC 
Cancer listserv approximately 2 weeks after the first letter was issued to increase participant 
response. All quantitative data were analyzed and reported using frequencies calculated by the 
Survey Monkey program. 
Part II: Patient Satisfaction 
 
The second part of the study was designed to assess patient satisfaction with the mode of 
BRCA1/2 genetic test results delivery. Surveys were mailed to 379 patients who had undergone 
BRCA1/2 genetic testing through the University of North Carolina Chapel Hill (UNC-CH) 
Cancer Genetics Clinic. A subset of patients, those who were African–American, were not 
invited into this study because they had previously been invited to participate in a concurrent 
study. The remaining patients were therefore randomized alphabetically by last name to 
participate in this study. The study sample included patients who did not have a choice as to how 
to receive their results (mostly patients seen prior to 2005 when the practice of the UNC Chapel 
Hill Cancer Genetics Clinic was to deliver all results in person) and patients who were provided 
a choice of telephone or in-person results disclosure (practice that began in 2005). 
The patient survey (see Appendix B) was created as an original measure after reviewing several 
genetic counseling satisfaction surveys posted on the NSGC website (Lea 1996; Middleton and 
Rodriguez 1997; Rhee-Morris 2006). The measure was used to assess an overall satisfaction 
score of the results session experience for each individual. Participants were provided with a list 
of statements pertaining to their results session and asked to strongly disagree, disagree, agree, or 
strongly agree with each statement using a summative Likert scale to calculate a total satisfaction 
score. These scores were then divided by the amount of the answered items to produce an 
average satisfaction score for each individual. These averaged scores where then used to 
compare satisfaction between those who received their results in-person versus those who 
received their results over the telephone. Satisfaction scores were also compared between those 
patients who reported that they had a choice as to how to receive their results versus those who 
reported not having had a choice. As the goal of our study was to evaluate satisfaction in the 
context of mode of results delivery and choice of mode of results delivery, for those individuals 
who may not have recalled how they received their genetic test results or whether they had a 
choice in their mode of results delivery, the option of “unsure” was provided for these questions 
to allow these responses to be eliminated in data comparison and analysis. 
To test the accuracy of patients’ recall of their results, surveys were color-coded depending on 
the type of result the patient received: positive (55 individuals), negative (307 individuals), or 
variant of unknown significance (17 individuals). Participants were asked to report their result 
and responses were checked for accuracy, without identifying individuals, by matching their 
response to the color-coded survey they were sent. 
Results were analyzed using SPSS. The satisfaction scores were checked for normality using 
One-Sample Kolmogorov-Smirnov Test and found to lack normality. Therefore, all comparisons 
of satisfaction scores between groups were made using nonparametric tests such as Kruskal-
Wallis Test, Man-Whitney Test, and Chi-Square analyses. Cross-Tabulations and frequencies 
were used to describe variables of the study population. 
Results 
 
Part I: Current Genetic Counseling Practices 
 
Of the estimated 476 genetic counselors belonging to the Cancer Special Interest Group, 107 
individuals responded to the invitation by completing the survey for a response rate of 
approximately 22.5%. Eight of the respondents (7.5%) reported that they had never delivered 
BRCA1/2 genetic test results to patients by telephone and were not asked to answer any further 
questions. 
Frequency of Phone Results Disclosure 
Of the 99 individuals who had delivered results by telephone in the past 12 months, the majority 
(63.9%) reported that 25% or less of their patient population received their BRCA1/2 genetic 
testing results in this manner (Fig. 1). 
 
Fig. 1 
Proportion of BRCA1/2 Tested Population to Whom Genetic Counselors Gave Results by 
Phone. 
Participating genetic counselors were asked to estimate how often they provided telephoned 
results in the past 12 months according to the type of result (Fig. 2). Counselors provided phone 
results “sometimes or usually” for positive, negative, or variant results 33.0%, 55.7% and 33.7% 
of the time, respectively. While there was no difference between the frequency of phone results 
among patients with positive or variant results (p = 0.9187), both positive and variant results 
were given significantly less often over the telephone than were negative results (Positive vs. 
Negative: OR = 0.39, CI 95% 0.22–0.70, p = 0.0015; Variant vs. Negative: OR = 0.40, CI 95% 
0.23–0.73, p = 0.0022.) 
 
Fig. 2 
Frequency of BRCA1/2 Test Results Delivery by Telephone According to Type of Result. 
Circumstances Surrounding Phone Disclosure 
 
Genetic counselors were provided with a list of possible circumstances under which one might or 
might not deliver BRCA1/2 genetic test results over the telephone and were asked for each 
circumstance whether they would “usually, sometimes, rarely or never” provide results by 
phone. In the positive result scenario, the most common preference was to never deliver this type 
of result by telephone, regardless of the circumstance provided (Table 1). From a list of possible 
circumstances under which a genetic counselor might give negative results, the most commonly 
chosen answer was also to never deliver this type of result over the telephone (Table 1). 
However, in specific circumstances, such as: “When patients are unable to return to clinic due to 
illness or travel issues” and “When I feel confident that I will have an opportunity to follow up 
with the patient face to face” the highest percentage of individuals (34.8% and 29.0% 
respectively) answered that they usually would deliver these negative test results over the 
telephone. 
Genetic counselors were also given the opportunity to provide open-ended responses regarding 
circumstances under which they might deliver positive and/or negative results over the 
telephone. Respondents’ reasons for providing phone results included: exceptional types of 
situations, routine practice by their institution, delivery of preliminary results while BART© (an 
additional testing method offered by Myriad Genetics Laboratory to high risk patients who 
receive negative results) results are pending, and delivery of BART results. 
Part II: Patient Satisfaction 
 
The primary goal of Part II in this study was to determine patient satisfaction at our institution 
with respect to how their BRCA1/2 results were delivered. The response rate for patient surveys 
was 36.1% (137/379). Demographics of responders are shown in Table 2. 
Table 2 
Patient Characteristics 
Race/Ethnicity % N 
Caucasian 93.4 128 
American Indian 0.7 1 
Other 1.5 2 
Missing 4.4 6 
Age 
 20–29 2.2 3 
 30–39 13.9 19 
 40–49 21.9 30 
 50–59 30.7 42 
 60–69 14.6 20 
 70–79 5.1 7 
Race/Ethnicity % N 
 80–89 0.7 1 
 Missing 10.9 15 
Gender 
 Male 4.4 6 
 Female 93.4 128 
 Missing 2.2 3 
Education 
 Less than high school 0.7 1 
 High school 5.8 8 
 Some College/Technical school 20.4 28 
 College 27.7 38 
 Some Graduate/Professional school 13.1 18 
 Graduate/Professional school 28.5 39 
 Missing 3.6 5 
Religion 
 Catholic 11.7 16 
 Jewish 16.8 23 
 Protestant 61.3 84 
Race/Ethnicity % N 
 Other 3.6 5 
 None 2.2 3 
 Missing 4.4 6 
Marital Status 
 Single 7.3 10 
 Living w/ partner 2.2 3 
 Married 75.9 104 
 Separated 1.5 2 
 Divorced 8.0 11 
 Widowed 1.5 2 
 Missing 3.6 5 
When Received Results 
 Prior to 2005 24.8 34 
 After 2005 75.2 103 
 
Patient Satisfaction by Mode of Results Delivery 
 
In general, most individuals were highly satisfied with the delivery of their results, reporting an 
average satisfaction score of 3.6 on a four point scale (n = 135). Notably, there was no significant 
difference in satisfaction between patients who received their results over the telephone and 
those who received their results in clinic (Table 3 ). No other factors, including the type of result, 
whether a patient was tested for a familial mutation, or the length of the results session, 
significantly correlated with patient satisfaction. 
Table 3 
Comparison of Satisfaction Between Various Groups 
Grouping Variable 
Specific 
Variables n 
Mean Rank Satisfaction 
(of 100)   
Telephone v. Clinic results (n = 131) 
Telephone 51 69.8 
p = .344 Clinic 80 63.6 
Reported result (n = 129) 
Negative 109 64.3 
p = .613 Positive 20 68.8 
Given a choice of how you received results 
(n = 101) 
Yes 37 59.3 
p = .024 No 64 46.2 
Tested for familial mutation (n = 122) 
Yes 34 59.7 
p = .716 No 88 62.2 
Time waited for results once you knew they 
were ready (n = 125) 
None 25 78.7 
p  < .001 
1 day 7 80.2 
1 week 36 73.3 
1 month 40 44.8 
> 1 month 17 53.8 
Length of results session (n = 133) 
15 min 59 68.3 
p = .546 30 min 50 68.2 
Grouping Variable 
Specific 
Variables n 
Mean Rank Satisfaction 
(of 100)   
1 h 22 58.6 
>1 h 2 91.5 
Statistical significance calculated by Mann Whitney & Kruskal Wallis Tests 
We also queried patients as to whether they would have rather received their results in a different 
way (Table 4). Of the 51 patients who received their results by phone, 50 responded to this 
question and five of them (10.0%) indicated that they would have preferred to receive their 
results in person. Of the 82 patients who received results in person, 79 responded and 11 of them 
(13.9%) reported that they would have preferred to receive their results by phone. There was no 
statistically significant evidence that a preference for receiving results in a different way was 
associated with the type of result delivered (p = 0.51). 
Table 4 
Assessment of Whether Patients Would Have Preferred a Different Mode of Results Delivery 
Reported Result 
N(%) 
Received Results By Telephone—Rather In 
Person? (N = 50) 
Received Results In Person—Rather Over 
Phone? (N = 79) 
YES NO YES NO 
Negative 5 (10.0%) 36 (72.0%) 9 (11.4%) 55 (69.6%) 
Positive 0 (0.0%) 7 (14.0%) 1 (1.3%) 11 (13.9%) 
VUS 0 (0.0%) 2 (4.0%) 1 (1.3%) 2 (2.5%) 
Total 5 (10.0%) 45 (90.0%) 11 (14.0%) 68 (86.1%) 
VUS Variant of unknown significance 
Patient Satisfaction by Time Waiting for Results 
 
Patients were also asked to indicate how long it took for them to receive their BRCA1/2 genetic 
test results once they knew the results were ready by checking one of several options provided 
(see Appendix B). The amount of time a patient waited for results once they knew the results 
were ready was significantly related to their satisfaction (p < 0.001). Patients who waited 1 
month or longer for their results were less satisfied than those who received their results in less 
time. 
Patient Satisfaction Regarding Choice of Mode of Results Delivery 
 
Those patients who had a choice of how to receive their results (those seen after 2005) reported a 
significantly higher mean rank of satisfaction (p = .024) when compared with those patients who 
reported not having a choice (those seen prior to 2005). 
Lastly, cross tabulations were utilized to assess patient accuracy in recalling the result that was 
provided to them. Of the 136 individuals who reported a result, 132 (97.1%) accurately recalled 
their result. Four (2.9%) individuals, however, did not accurately recall their provided result. 
Three of these four individuals had received a result which involved a variant of uncertain 
significance. Of the four patients who did not accurately recall their result, three had received 
their results in-person (Table 5). 
Table 5 
Scenarios of Four Patient Respondents whose Actual and Reported Results were Discordant 
 Actual Result Reported Result Mode of Results 
Delivery 
Patient 1 Negative Positive In Person 
Patient 2 Negative VUS Telephone 
Patient 3 Negative VUS In Person 
Patient 4 VUS Negative In Person 
 
Discussion 
 
Provision of BRCA1/2 genetic testing results by telephone is not rare among genetic counselors, 
but is provided to a minority of patients. The majority of counselors report that they deliver such 
results by telephone to less than 25% of their patient population. Even in exceptional 
circumstances, a large proportion of counselors would still never consider delivering these 
results by telephone. Although counselors are more likely to deliver negative (as opposed to 
positive) results over the telephone, the majority of counselors would still encourage patients to 
come into clinic to receive their results in all circumstances. 
In our study, patients themselves exhibited no difference in satisfaction when their results were 
delivered over the telephone versus in clinic. These results are consistent with previous study 
results (Chen et al. 2002; Jenkins et al. 2007) and suggest that provision of results by telephone 
can be an acceptable practice in the setting of cancer genetics. 
Two other findings were important with respect to patient satisfaction. First, patients who 
received their results within 1 week of knowing that their results were available were 
significantly more satisfied than those that had to wait a month or longer for their results. Thus, 
when dealing with a test like BRCA1/2 which often takes several weeks to be performed, 
providing results by telephone may be one way to increase patient satisfaction with the testing 
and counseling process. Second, our results demonstrate that patients who were given a choice of 
how they wanted to receive their results were more satisfied with their results session than those 
who were not given a choice. While the field of genetic counseling has focused on the pros and 
cons of telephone delivery of results, the current study suggests that perhaps the conversation 
should shift to discussing whether clinics should offer the option of how to receive one’s results 
instead of prescribing the mode of delivery. Such deference to patient autonomy is fully in 
keeping with the tradition of genetic counseling in which patient autonomy and choice have been 
of paramount concern. The results of this study support the notion that it is the autonomy to 
choose that impacts patient satisfaction, not the specific mode of delivery. 
While the number of individuals correctly recalling the result provided to them is encouraging 
(~97%), it should be noted that a few individuals inaccurately recalled their specific result. 
However, as previously mentioned, three of these four individuals’ results were variants of 
unknown clinical significance. These variant results may have been reclassified since the time of 
initial results disclosure or deemed low enough risk to have been considered negative. Therefore, 
it is uncertain whether these three individuals actually inaccurately recalled their result. The 
fourth individual who inaccurately recalled the test results actually received a negative result but 
recalled having received a positive result. Again, it is unclear from the information we have 
whether this is an example of incorrect comprehension on the part of the patient or if, for 
example, the negative was considered to be a false negative. However, future studies aimed at 
investigating patient comprehension of variants of unknown significance may be warranted. 
While no firm conclusions can be gleaned from the four instances of apparent misunderstanding 
of patients regarding their results, it is worth noting that in three of the four cases of incorrect 
recollection, the patients had received results in-person. 
This study found supportive results for the routine provision of BRCA1/2 genetic test results by 
telephone, and was designed to assess counselor practice and patient satisfaction with this mode 
of results delivery. However, there were a number of limitations to the current study. Counselor 
and patient response rates were not high (22.5% and 36.1% respectively), and therefore cannot 
be assumed to be entirely representative of these populations. Selection bias cannot be ruled out 
and the exclusion of African American individuals due to a concurrent study also limits the 
generalizability of results. Reliance on estimation and recall for both counselors and patients also 
limits this study since genetic counselors were asked to estimate past and present practices in 
regards to delivery of BRCA1/2 genetic test results by telephone. Patients were asked to recall 
their experiences with receiving their results, which in some cases occurred greater than 3 years 
ago. However, this specific limitation was addressed in the survey design by giving patients the 
option to answer ”unsure” to many of the questions, allowing those responses to be eliminated in 
data comparisons and analysis. 
Another limitation of this study stems from the fact that some individuals received results before 
2005 (those who were not given a choice in their results method) and were compared with a 
group of later patients who were given an option. Time-based factors could have affected patient 
satisfaction responses that were not related specifically to the mode of disclosure. However, the 
stable nature of the clinic and personnel throughout both periods of time should have minimized 
such concerns. 
Conclusion 
 
As genetics increasingly permeates medicine, genetic testing will become commonplace. It is 
critical that our field continue to explore optimal means of delivering results with an eye towards 
maintaining professional standards, accuracy and patient satisfaction, while at the same time 
seeking maximal efficiency. The results of this study suggest that results should be delivered as 
swiftly as possible once they are available, and that offering patients a choice of how to receive 
results is desirable. If future studies confirm that patients are more satisfied with choice, and that 
there is little difference in patient comprehension and retention of knowledge by telephone 
versus in person, then the option of results by telephone, perhaps with the option of a follow-up 
session if desired, should become the standard mode of delivery for most genetic testing results. 
Such considerations are of great importance as medicine struggles to incorporate an increasing 
volume of genetic data into daily practice while maximizing efficiency and appropriately caring 
for the increasing number of patients receiving genetic testing. 
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